| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000243224.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045256202 |
Resistant |
| ENSG00000243224.1 |
Ponatinib |
Sarcoma |
0.016878604 |
Sensitive |
| ENSG00000243224.1 |
Ponatinib |
Skin cutaneous melanoma |
0.039564718 |
Sensitive |
